Antibiotic susceptibility and fosfomycin resistance characterization in a cohort of children older than 6 years of age with urinary tract infection

Rev Argent Microbiol. 2022 Apr-Jun;54(2):120-124. doi: 10.1016/j.ram.2021.04.002. Epub 2021 Jun 19.

Abstract

Fosfomycin tromethamol (FT) was reintroduced as an option for the treatment of low urinary tract infection (UTI) in children. In this study, we described the antibiotic sensitivity and mechanisms of resistance to fosfomycin in isolates from children older than 6 years with UTI. Urine culture and antibiotic susceptibility study were performed. In fosfomycin resistant strains, PCR for fos, blaCTX-M was performed followed by classification by phylogenetic group and sequencetyping. Escherichia coli was the most frequent etiological agent (89.2%). The susceptibility percentages were: fosfomycin 97.9%; amoxicillin-clavulanate 92.7%; cefuroxime and ceftriaxone 99%; nitrofurantoin 94.4%. An E. coli strain (ST69, phylogenetic group D) was resistant to fosfomycin (MIC 256mg/l) and carried the blaCTX-M-14 and fosA3 genes in a 45kb IncN-type plasmid. This is the first report of E. coli ST69 with blaCTX-M-14/fosA3 of human origin.

Keywords: Children; Escherichia coli; Fosfomycin resistance; Infección urinaria; Niños; Resistencia a fosfomicina; Urinary tract infection; fosA3.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Child
  • Drug Resistance, Bacterial
  • Escherichia coli / genetics
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / epidemiology
  • Fosfomycin* / pharmacology
  • Fosfomycin* / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Phylogeny
  • Urinary Tract Infections* / drug therapy
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Fosfomycin
  • beta-Lactamases